Atlas Trials

Lenvatinib

24 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Lenvatinib

RecordFirmDate
Study of TACE Combined With Lenvatinib to Prevent Postoperative Recurrence in Patients With MVI Positive HCC (NCT04911959)Second Affiliated Hospital, Zhejiang University, School of Medicine2022-07-01
Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma (NCT05444478)Sun Yat-sen University2022-07-01
Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma (NCT04955743)Yale University2022-02-09
Tislelizumab（Anti PD-1), Lenvatinib and GEMOX Transformation in the Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer (NCT05156788)Shanghai Zhongshan Hospital2021-12-12
Phase II Study of Concurrent Lenvatinib and Radiotherapy for Advanced HCC (NCT04791176)Cancer Institute and Hospital, Chinese Academy of Medical Sciences2021-04-12
Clinical Study of the Efficacy and Safety of Transhepatic Arterial Chemoembolization Combined With Tislelizumab and Lenvatinib in Patients With Advanced Unresectable Hepatocellular Carcinoma (NCT05131698)Cancer Hospital of Guangxi Medical University2021-03-01
Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors (NCT04669496)Shanghai Zhongshan Hospital2021-01-20
HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416) (NCT06631326)First Hospital of China Medical University2021-01-01
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma (NCT06333561)Sun Yat-sen University2021-01-01

Track Lenvatinib automatically

Every clearance here is in the API, with alerts when new ones post.